Blue powder from a round blue tablet with ''K 0'' imprint spanning vertical break line. No markings on other face. [DrugsData accepts partial tablets and pulverized tablets by prior approval only.]
Jan 04 2022: Sample was re-analyzed and has been confirmed as containing only methocarbamol with quetiapine. Originally guaifenesin was identified as also being present. Methocarbamol breaks down in GC/MS to guaifenesin, and the breakdown ratio is similar to the ratio of guaifenesin and methocarbamol in this sample.
Nov 22 2021: The lab is ordering a reference standard for methocarbomal to re-analyze this sample.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Nov 22 2021: The lab is ordering a reference standard for methocarbomal to re-analyze this sample.